Bio-Techne
TECH
#1429
Rank
$12.13 B
Marketcap
$77.02
Share price
-0.38%
Change (1 day)
-8.55%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

P/S ratio for Bio-Techne (TECH)

P/S ratio as of July 2024 (TTM): 10.6

According to Bio-Techne's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.5545. At the end of 2024 the company had a P/S ratio of 9.59.

P/S ratio history for Bio-Techne from 2001 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20249.59-10.06%
202310.7-8.26%
202211.6-41.16%
202119.728.67%
202015.335.99%
201911.340.86%
20188.01-1.07%
20178.1011.46%
20167.260.94%
20157.20-14.26%
20148.39-20.67%
201310.631.29%
20128.06-2.18%
20118.24-7.85%
20108.94-7.32%
20099.657.08%
20089.01-16.95%
200710.85.15%
200610.3-9.54%
200511.419.31%
20049.56-5.57%
200310.117.54%
20028.61-31.35%
200112.5

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
4.92-53.35%๐Ÿ‡บ๐Ÿ‡ธ USA
3.29-68.83%๐Ÿ‡บ๐Ÿ‡ธ USA
3.36-68.18%๐Ÿ‡บ๐Ÿ‡ธ USA
8.11-23.12%๐Ÿ‡บ๐Ÿ‡ธ USA
4.83-54.27%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
2.50-76.28%๐Ÿ‡บ๐Ÿ‡ธ USA
12.6 19.79%๐Ÿ‡บ๐Ÿ‡ธ USA